MedTrace Logo

Data Visualization of Kidney and Prostate Tumors Using Routine Pre-Operative Imaging, 3D Printed, and 3D Virtual Reality Models

NCT03656822 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 303

Last updated 2020-02-06

No results posted yet for this study

Summary

The purpose of this study is to determine whether adding new methods of data visualization to routine clinical care will improve (i) surgical planning and (ii) surgical outcomes in patients with kidney and prostate tumors.

Conditions

  • Pleural Effusion

Interventions

DIAGNOSTIC_TEST

Routine CT

CAT (Computerized Axial Tomography) scan, is a noninvasive X-ray test that is used to diagnose a variety of medical conditions.

DIAGNOSTIC_TEST

Routine imaging CT with a 3D printed model

CAT (Computerized Axial Tomography) scan, is a noninvasive X-ray test that is used to diagnose a variety of medical conditions + 3D Printed Model

DIAGNOSTIC_TEST

Routine imaging MRI with a 3D printed model

will measure post-operative lesion volume as visualized on the post-operative MRI + 3D Printed Model

DIAGNOSTIC_TEST

Routine MRI

will measure post-operative lesion volume as visualized on the post-operative MRI

DIAGNOSTIC_TEST

Routine imaging CT with a VR model

CAT (Computerized Axial Tomography) scan, is a noninvasive X-ray test that is used to diagnose a variety of medical conditions + VR Model

DIAGNOSTIC_TEST

Routine imaging MRI with a VR model

will measure post-operative lesion volume as visualized on the post-operative MRI + VR Model

Sponsors & Collaborators

Principal Investigators

  • Hersh Chandarana, MD · NYU Langone Health

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-07
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03656822 on ClinicalTrials.gov